was found between IMT and age (R 2 = 0.35, p < 0.0001) and estrogen therapy duration (R 2 = 0.65, p < 0.0001), suggesting a clear tendency toward a premature decrease in FMD and premature increase in IMT compared to controls. Conclusions Young TS patients show an arterial wall which is functionally and structurally comparable or betterthan controls. They show, however, a premature derangement of the arterial function and structure, which seems to be partly influenced by age and duration of oestrogen treatment.
Introduction
Patients with Turner syndrome (TS) are frequently affected by cardiovascular diseases, which are also the main cause for their higher mortality rate [1] [2] [3] . Most defects are congenital and left-sided but acquired diseases such as aortic dissection and ischemic heart diseases are increasingly reported [4, 5] . Hypertension is also very often found [4] . Previous studies have indicated that hypertension in TS affects pulse pressure and that there is a blunted nocturnal dipping pattern [6, 7] . Furthermore, studies indicate that morbidity and mortality directly attributed to hypertension are substantial (RR 2.9 and SMR 6.0) [8, 9] .
However, although hypertension has been reported in 7-17 % of children and in 24-40 % of adults [10] , no clear cause has been identified, when renal disease or aortic coarctation have been excluded. Recently a decreased sympathovagal balance has been proposed as a concomitant cause for the hypertension [7] . Abnormalities in arterial function and structure could play a role in the progression
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Purpose Patients with Turner syndrome (TS) are frequently affected by congenital as well as acquired cardiovascular diseases. The aim of the study was to evaluate the blood pressure, the endothelial function (FMD) and the intima media thickness (IMT) at the level of the common carotid arteries in a group of girls and young women with TS in comparison to healthy controls. Methods We evaluated 40 unselected TS patients, with a mean age of 18.6 ± 0.9 years and 103 age matched healthy subjects. Main outcome measures: blood pressure, FMD and IMT. Results No differences were found in systolic and diastolic blood pressure between TS patients and controls. FMD was higher in TS than in controls (14.2 ± 1.4 vs 11.4 ± 0.3 %, p = 0.005) whereas IMT was not statistically different in the two study groups (0.54 ± 0.04 vs 0.57 ± 0.01 mm). However, in TS patients an inverse correlation was found between FMD and both age (−0.03 ± 0.01, p = 0.003) and years of estrogen therapy (−0.72 ± 0.31, p < 0.03), whereas a positive correlation of the cardiovascular disease [11] [12] [13] . Endothelial dysfunction is thought to be an important factor in the development of atherosclerosis, hypertension and heart failure [14, 15] and carotid intima media thickness (IMT) is considered a predictor of adverse cardiovascular prognosis [16] . The aim of our study was to evaluate endothelial dysfunction and arterial structure by means of flow mediated dilation (FMD) and IMT, in a group of girls and young women with TS.
Patients and methods

Patients
Forty patients with TS with a mean age of 18.6 ± 0.9 years (range 8-35 years) were enrolled into the study. They were the first 40 TS patients who agreed to participate into the study. They were regularly followed-up in three inpatient paediatric endocrinology units and in one adult endocrine unit. Exclusion criteria were concomitant cardiovascular diseases, and any medications which could interfere with cardiovascular evaluation.
Sixteen subjects were reported to be affected by Hashimoto's thyroiditis (40 %); 12 were not receiving any treatment because still euthyroid or only mildly hypothyroid (TSH 4.5-10 mU/l) and 4 were treated with l-thyroxine because of hypothyroidism (TSH >10 mU/l; range 12-84 mU/l). At the time of the investigation all patients were euthyroid while taking regularly, if needed l-thyroxine. Two had celiac disease, seven had kidney abnormalities such as nephrolitiasis (#1), double district (#3), renal ectopia (#1), horse-shoe kidney (#1) and hydronephrosis (#1). No patients suffered from diabetes mellitus.
Chromosomal analysis was performed and 45,X karyotype was found in 55 % of subjects (22 pts), structural abnormalities of the X chromosome (X-SA) in 22.5 % (9 pts) and X-mosaicism in 20 % (8 pts) and Y-mosaicism in 2.5 % (1 pts). Six subjects were prepubertal, one was in midpuberty (Tanner stage 3) at the time of the study, while the others were allpubertal/postpubertal following spontaneous (9) or artificially induced (17) sexual development. Puberty was induced by administering low doses of ethynilestradiol orally (2.5 µg daily), increasing progressively. After 2 years or in case of bleeding a progestin was added. Thirty-six patients were treated with recombinant GH for 5.6 ± 2.7 years (range 0.25-11 years); 22 of them were off treatment, while 14 were on treatment at the time of the study.
One hundred and three subjects with a mean age of 19.0 ± 0.5 years (range 8.5-30 years) were studied as a pooled cohort of controls. They were recruited from a group of healthy subjects according to a cooperative study program between our centers and the family paediatricians as well as general practitioners. The appropriate review board approved the clinical protocol, and written informed consent for all procedures was obtained from all subjects or from their legal guardians before enrolment.
Methods
Study protocol
All subjects were admitted to the ward after a night fast. Blood samples were collected for the assessment of totalcholesterol and HDL-cholesterol, triglycerides, insulin and glucose serum levels. Height and weight were measured and body mass index (BMI) (kg/m 2 ) calculated. Height and BMI were converted to SDS according to Cacciari et al. [17] .
Systolic (SBP) and diastolic (DBP) blood pressure were measured at the right arm by a cuff manometer after 5 min of supine rest according to the fourth report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents [18] . Two BP measurements were obtained 5 min apart, and the means of the two SBP and DBP measurements were used in the analysis Insulin resistance was evaluated by HOMA-R [fasting insulin (mU/l) × fasting glucose (mmol/l)/22.5] [19] . Insulin sensitivity was evaluated with QUICKI 1/[log (I 0 ) + log (G 0 )], where I 0 is the fasting insulin and G 0 the fasting glucose [20] .
In the same session FMD to assess the endothelial function and IMT measurements to assess arterial structure were evaluated.
Flow-mediated dilatation was assessed by the same operator in each center, using the same high-resolution ultrasound device (Philips IE 33) to measure brachial artery responses to reactive hyperaemia, according to the recently published guidelines [21] . The dilatation of the artery caused by the increased blood flow is known as flow-mediated dilatation. A 12 MHz linear phased array transducer and a high-resolution ultrasonic vessel wall tracking system were used to image the dominant arm brachial artery longitudinally, just above the antecubital fossa. Brachial artery diameter was measured using electronic calipers from the anterior to the posterior-line at a fixed distance from an anatomic marker. Images were acquired at baseline, during hand hyperaemia, i.e., 90 s after deflation of a wristcuff inflated to suprasystolic pressure (at least 50 mmHg above systolic pressure) for 5 min for measurement of FMD. FMD was calculated as the percentage increase in arterial diameter during hyperaemia compared with the diameter at rest.
Carotid Intima Media Thickness was performed according to standardized scanning protocol [12] for the right and the left carotid arteries, i.e., using images of the far wall of the distal 10 mm of the common carotid artery bifurcation using high resolution B-mode real-time ultrasound. IMT was defined by the lumen-intima and media-adventitia interfaces of the far wall. Three measurements were taken for both parameters on each side, and the mean of right and left taken as the overall average IMT.
The intra-and inter-CV for FMD were 0.3 and 1.5 %, respectively, while the intra-and inter-CV for IMT were both <9 %. Within TS group, almost all patients performed all the evaluations included in the study protocol; within controls, only FMD was performed by the entire cohort of 103 subjects, whereas a variable number of subjects (ranging from 56 to 59) underwent all other evaluations and measurements (see Table 1 for details).
The study was approved by the local ethical committee and informed consent was obtained from all patients.
Assays
Serum glucose, insulin, total-cholesterol, HDL-cholesterol and triglycerides were measured and the assays were performed in each center with comparable method of analysis.
Serum glucose was measured with automatic analyzers, using an hexokinase catalyzed-glucose oxidase method. Serum insulin concentrations were measured by using a solidphase, enzyme-labeled chemiluminescentimmunometric assay (IMMULITE 2000 Insulin).
Serum triglycerides, total and HDL cholesterol were determined by an enzymatic in vitro test using Roche automated clinical chemistry analyzers (Roche Diagnostics, Mannheim, Germany).
Statistical analysis
Data are presented as mean ± SEM. Variables were analyzed by the Kolmogorov-Smirnov test, and positively skewed variables were log transformed for analysis.
Clinical and demographic characteristics were compared between participants, using analysis of variance for continuous variables and χ 2 test for dichotomous or categorical variables. General linear models were used to evaluate factors associated with FMD. Crude and adjusted for age p value 
Results
Clinical parameters
As expected TS patients were shorter than controls (HSDS −1. (Table 1 ).
Blood pressure
At univariate analysis systolic (113.3 ± 1.6 vs 118.2 ± 1.3 mmHg, p = 0.01) and diastolic BP (69.4 ± 1.4 vs 75.5 ± 0.9 mmHg, p < 0.001) were lower in TS than in controls (Table 1) , but adjusting the model by age, BMI, BSA and HOMA-R, the differences were no more significant (Table 2) .
Flow-mediated dilatation
FMD was higher in TS-patients compared to controls (14.2 ± 1.4 vs 11.4 ± 0.3 %, p = 0.005) ( Table 1) . At multiple regression analysis, adjusting the model by chronological age, BMI, BSA, cholesterol, HOMA-R and BP, the difference in the FMD between TS and controls persisted independently of potential confounders (Table 2 ). An inverse correlation was found between FMD and age (−0.03 ± 0.01, p = 0.003) in TS with a clear tendency towards a premature decrease in FMD compared to controls (Fig. 1a) .
Intima media thickness
No difference in IMT was found between TS-patients and controls (0.54 + 0.04 vs 0.57 + 0.01, respectively) also adjusting the model by CA, BMI, BSA, cholesterol, HOMA-R and BP at multiple regression analysis. The association between IMT and age (R 2 = 0.35, p < 0.0001), showed a departure from linearity, and the quadratic term reached a statistically significant level both in TS and in controls (Fig. 1b) . IMT increased significantly with age both in TS and in controls with no difference between groups.
Effects of GH-therapy and oestrogen-therapy on FMD and IMT
An inverse association was found between FMD and estrogens-therapy duration (years of therapy) (−0.72 ± 0.31, p < 0.03), while IMT correlated positively with oestrogens duration (R 2 = 0.65, p < 0.0001). In TS group oestrogen dosage and GH-therapy did not influence FMD and IMT. 
Discussion
The results of this study in a group of TS patients are only partly reassuring. In our study we did not find significant differences in SBP and DBP in TS compared to healthy controls, after controlling for age, BMI, BSA and HOMA-R. IMT was not altered and the arterial function expressed as FMD was even better than in controls. However, there was a clear tendency in these patients towards a premature decrease in FMD and also an early increase of IMT with advancing age.
Furthermore, many metabolic parameters were altered in our young TS patients; indeed they showed higher serum cholesterol levels and insulin resistance values in respect to controls, which are considered predictive markers of cardiovascular disease [11, 13] . We wondered whether the paternal origin of X chromosome might explain the altered lipid profile, since higher total and low-density lipoprotein cholesterol have been reported in those who retained the paternal chromosome [22] . In that paper however, the different lipid profile between TS with different origin of X chromosome disappeared after GH treatment and since our young patients were still on treatment or just discontinued it, we do not think that this observation can explain our data.
Related studies in the literature do not report unanimous results. Concerning blood pressure, our results are in agreement with those of Mortensen [23] and Baguet [11] who found similar values in patients and controls, while Ostberg A B [12] , on the contrary, observed a higher blood pressure in TS patients. The difference might be explained by the different age of the subjects, ours being younger than those of Ostberg, as well as by the different methods of BP evaluation since we did not perform a 24 h profile. Arterial wall distensibility, which was evaluated directly in our patients by means of the flow-mediated dilatation, was found to be normal and better than in controls, even after adjusting the model for potential confounders such as CA, BMI, BSA, cholesterol, HOMA-R and BP, CA, BMI, BSA, cholesterol, HOMA-R and blood pressure. Baguet and Ostberg also evaluated arterial wall distensibility by means of pulse wave velocity, which is an indirect method, and they did not find any difference between patients and controls [11, 12] . However, when Baguet et al. [11] corrected the results for the body surface area and for the heart rate, they found a higher pulse wave velocity for the body surface area and a lower pulse wave velocity for the heart rate in TS patients. Van den Berg observed an altered aortic distensibility only at the diaphragmatic level, using MRI imaging [13] . A fact that could explain some differences in the studies is the younger age of our patients and the fact that we excluded a priori all patients with a congenital cardiopathy, while in the studies of Baguet and Ostberg 27.9 and 25 % of the patients, respectively, had some kind of cardiomyopathy [11, 12] . At multiple regression analysis, in fact, we found that FMD was inversely correlated with age and years of oestrogen treatment. Different investigational techniques might also explain the differences.
Arterial morphology, evaluated measuring the carotid intima media thickness, was the same in TS group and controls. These findings are in partial agreement with those of Baguet et al. [11] , who investigated a similar group of young TS patients. Concerning the older patients, the literature provides conflicting data: Ostberg [12] found an increased IMT in his patients, whereas recently Mortensen [24] found lower levels of IMT in a TS subgroup on oestrogen therapy than in older subjects without treatment.
In our study the association between IMT and age showed a non-linear response in both groups (Fig. 1b) , but with a steeper curve in TS patients. This suggests a more rapid worsening of the arterial structure with advancing age in these subjects.
We considered the role played by growth hormone or oestrogen treatment in our findings. Both hormones are known in fact to have significant cardiovascular effects. GH has been shown to improve FMD [25] , to decrease IMT [26] and to reduce diastolic BP via a reduction in peripheral vascular resistance in adult hypopituitary subjects [27] . In a previous paper we also found that GH was able to induce a significant peripheral vasodilatation in TS patients [28] . In the present study, however we did not find evidence for a role of GH on blood pressure, arterial function and structure.
Different forms of oestrogen treatment may also have played a role, since oestrogens have been shown to improve cardiovascular hemodynamics [29, 30] , insulin sensitivity [29] and to reduce stiffness in the large vessels [31] . In fact we found an inverse correlation between oestrogen treatment duration and FMD.
As to the influence of oestrogens on the arterial structure, it has been reported that they seem to have a differential effect at different stages of the atherosclerotic disease process, with beneficial anti-atherogenic effects earlier in life, but proinflammatory and prothrombotic effects predominate in the older, postmenopausal age group [32] [33] [34] . If we accept that TS patients have a genetically determined arterial wall defect [12] causing precocious atherosclerosis, then we can explain the steep curve that they show in the correlation between IMT and age (Fig. 1b) , which suggests a deleterious effect of oestrogens on a prematurely deteriorating arterial wall. TS patients therefore behave like postmenopausal women, already showing some arterial alterations secondary to an intrinsic arterial wall defect.
Progesteron may also explain the premature derangement of vascular function and structure, since it has been shown to favour arterial wall injury by opposing the antioxidant effect of estrogen on LDL and the arterial wall. Older TS femaleswere in factalso receiving progesterone, in addition to estrogen [35, 36] .
Insulin resistance is a common finding in TS girls [37, 38] and is reported to be independently associated with arterial stiffness in adult non-diabetic subjects [39, 40] because of its effects of increasing sympathetic tone, activation of the renin-angiotensin-aldosterone system and increased vascular inflammation. However, in our study Homa index was higher compared to controls but still within normal values. Furthermore, no statistical correlation was found in our patients with the parameters of arterial function and structure.
In conclusion, young TS patients show an arterial wall which is functionally and structurally comparable or better than controls. They show, however, a premature derangement of the arterial function and structure, which seems to be partly influenced by age and duration of estrogen treatment. The small number of patients evaluated in our study, does not permit definitive conclusions.
